| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/16/2003 | EP1150981B1 Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv |
| 04/16/2003 | EP1121100B1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/16/2003 | EP1105099B1 Fish gelatinous composition for use as an ingredient in tablets |
| 04/16/2003 | EP1104288A4 Orally disintegrable tablet forming a viscous slurry |
| 04/16/2003 | EP1100472B1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 04/16/2003 | EP1096921B1 Liposomal encapsulated nucleic acid-complexes |
| 04/16/2003 | EP1094791B1 Thixotropic formulations for filling capsules |
| 04/16/2003 | EP1083901B1 Efavirenz compressed tablet formulation |
| 04/16/2003 | EP1054691B1 Anti-enzyme antibodies for the treatment of the skin |
| 04/16/2003 | EP1051156B1 Pharmaceutical compositions |
| 04/16/2003 | EP1045686B1 Container for an inhalation anesthetic |
| 04/16/2003 | EP1028718B1 Extended release formulation containing venlafaxin |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0930933B1 Method for releasing an active principle contained in a multiple emulsion |
| 04/16/2003 | EP0927032B1 Buccal, non-polar spray for nitroglycerin |
| 04/16/2003 | EP0921810B1 Reduction of the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 04/16/2003 | EP0920337B1 Use of inorganic aerogels in pharmacy |
| 04/16/2003 | EP0910344B1 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| 04/16/2003 | EP0904055B1 Buccal, non-polar spray or capsule |
| 04/16/2003 | EP0893998B1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 04/16/2003 | EP0885016B1 Thermally stabilized contrast agent |
| 04/16/2003 | EP0861032B1 Aquatic animal treatment method and composition containing cajeput oil |
| 04/16/2003 | EP0806942B1 Starch acetate composition with modifiable properties, method for preparation and usage thereof |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0792154B1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/16/2003 | EP0752838B1 Stable suppository formulations of delta-9-thc (tetrahydrocannabinol) |
| 04/16/2003 | EP0737069B1 Deuterised active agents in transdermal application |
| 04/16/2003 | EP0734252B1 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 04/16/2003 | EP0686031B1 Dye compositions and methods for film coating tablets and the like |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/16/2003 | CN1411508A Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411388A Methods for extraction and reaction using supercritical fluids |
| 04/16/2003 | CN1411380A Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 04/16/2003 | CN1411373A Novel processes for making-and new crystalline form of-leflunomide |
| 04/16/2003 | CN1411372A Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/16/2003 | CN1411371A Compressed microparticles for dry injection |
| 04/16/2003 | CN1411369A Biodegradable microparticles with novel erythropoietin stimulating protein |
| 04/16/2003 | CN1411368A Method for producing liposome preparation |
| 04/16/2003 | CN1411367A Suspension comprising oxcarbazepine |
| 04/16/2003 | CN1411343A Chewing gum composition |
| 04/16/2003 | CN1411337A Anthelmintic compositions |
| 04/16/2003 | CN1411335A Fluid insecticidal formulations for dermal treatment of parasitic insect larvae |
| 04/16/2003 | CN1410725A Slow releasing device for volatile medicine and air conditioner using same |
| 04/16/2003 | CN1410461A (Methyl) hydroxyalkyl acrylate (co) polymer, preparing process and its use |
| 04/16/2003 | CN1410413A Naprosyn precusor, its synthesis method and application |
| 04/16/2003 | CN1410151A High adsorptivity light catalyzed air processor |
| 04/16/2003 | CN1410124A Spray for treating sound of snoring |
| 04/16/2003 | CN1410113A Plaster for treating femur necrosis due to deficiency of blood and its preparation method |
| 04/16/2003 | CN1410112A Fuyuan plaster for promoting blood circulation |
| 04/16/2003 | CN1410107A Xiatare tablet and its preparation method |
| 04/16/2003 | CN1410106A Xiatare ointment and its preparation method |
| 04/16/2003 | CN1410105A Zibei Cough stopping granules and its preparation method |
| 04/16/2003 | CN1410103A Ointment for eliminating macula and its preparation method |
| 04/16/2003 | CN1410102A Ointment for eliminating macula and its preparation method |
| 04/16/2003 | CN1410094A Ointment for treating nuchal rigidity |
| 04/16/2003 | CN1410087A Pain eliminating liquor No.1 |
| 04/16/2003 | CN1410084A Xiaoliufengtong injection liquid for eliminating tumour |
| 04/16/2003 | CN1410081A Capsule for treating rheumatism, rheumatoid archritis |
| 04/16/2003 | CN1410079A Curcuma zedoary oil nano capsule freeze dried ampoule powder for injection and its preparation technology |
| 04/16/2003 | CN1410068A Preparation method of water soluble tanshinone |
| 04/16/2003 | CN1410067A Chloromycetin kibe ointment |
| 04/16/2003 | CN1410066A Ursolic acid poly lactic acid nano particle freeze dried powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410065A Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410064A Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410063A Embedding agent for long acting blood pressure reducing |
| 04/16/2003 | CN1410061A Nimudipin undertongue spraying agent |
| 04/16/2003 | CN1410060A 苦参碱阴道凝胶 Matrine vaginal gel |
| 04/16/2003 | CN1410056A Preparation method of water soluble anticancer medical microsphere |
| 04/16/2003 | CN1410055A Vitamin A liposome and its preparation method |
| 04/16/2003 | CN1410054A II type collagen water soluble dispersion composition, its preparation method and application |
| 04/16/2003 | CN1409995A Synthetic sweetener |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/16/2003 | CN1105596C Method for producing small-particle prepns. of biologically active substances |
| 04/16/2003 | CN1105557C Sustained releasable parenteral pharmaceutical preparations and method of producing same |
| 04/16/2003 | CN1105551C Aqueous product comprising stable oil microdroplets and producing method thereof |
| 04/15/2003 | US6548687 Chromium L-threonate, process for preparation of the same and their use |
| 04/15/2003 | US6548630 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 04/15/2003 | US6548556 Stable enzymatic wound debrider |
| 04/15/2003 | US6548555 Solubility in small intestines; hydroxypropyl methyl cellulose acetate succinate polymer and zwitterion drug; |
| 04/15/2003 | US6548554 Ionic aqueous composition containing levomenthol |
| 04/15/2003 | US6548542 Vision through photodynamic therapy of the eye |
| 04/15/2003 | US6548513 (E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(methyl -sulfonyl)amino)pyrimidin-5-yl)-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or salt, stabilized by an inorganic salt having a multivalent cation, excluding synthetic hydrotalcite |
| 04/15/2003 | US6548491 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/15/2003 | US6548490 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 04/15/2003 | US6548487 Agent for treatment of bladder troubles |
| 04/15/2003 | US6548478 Virginiamycin mixture |
| 04/15/2003 | US6548302 Polymers for delivery of nucleic acids |
| 04/15/2003 | US6548171 Fluorescent nanocrystal-embedded microspheres for fluorescence analyses |
| 04/15/2003 | US6548170 Treated water-insoluble solid particles, preparation and use |
| 04/15/2003 | US6548095 Sugar-free compressed products |
| 04/15/2003 | US6548084 Controlled release compositions |
| 04/15/2003 | US6548083 Prolonged release active agent dosage form adapted for gastric retention |
| 04/15/2003 | US6548082 Sleep disorders |
| 04/15/2003 | US6548079 Moxifloxacin formulation containing common salt |
| 04/15/2003 | US6548078 Implanting a sustained release device to deliver the corticosteroid to the vitreous of the eye and wherein aqueous corticosteroid concentration is less than vitreous corticosteroid concentration during release |
| 04/15/2003 | US6548071 Lyophilizate of lipid complex of water insoluble camptothecins |
| 04/15/2003 | US6548053 Administering enzyme inhibitor |
| 04/15/2003 | US6548049 Medicinal aerosol formulation |
| 04/15/2003 | US6547997 Method for producing solvent-free noncrystalline biologically active substances |